Why are you looking at Nuclear Diagnostic Products of Philadelphia?
Email me when a Nuclear Diagnostic Products of Philadelphia recompete window opens.
Capability
Service linesPHARMACEUTICAL PREPARATION MANUFACTURING
Work mix: 100% prime · 0% sub · primary NAICS 325412 / PSC 6505 DRUGS AND BIOLOGICALS
Where they win
Sole agencyRecompete exposure: Moderate · 2 in 24mo
Nuclear Diagnostic Products of Philadelphia has an estimated $1.3M in contracts returning to market over the next 24 months.
Agency buyer map
1 buyersRecompete exposure
ModerateNuclear Diagnostic Products of Philadelphia has an estimated $1.3M in contracts returning to market over the next 24 months. 1 within 6 months ($1.2M).
“After 35 years in federal contracting, I've seen what separates the firms that win from the ones that wonder why they lost. What SCOUT does is put the kind of competitive and market intelligence in front of BD teams…”
Enter your company name and we'll build the page.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →
Frequently asked questions
What federal contracts does Nuclear Diagnostic Products of Philadelphia hold?
Nuclear Diagnostic Products of Philadelphia (UEI QJKJD5FKTNP3) shows $6.3M across 23 award actions in SCOUT’s public USASpending-backed profile, with Department of Veterans Affairs (VA) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.
How much in federal contracts does Nuclear Diagnostic Products of Philadelphia have?
Nuclear Diagnostic Products of Philadelphia shows $6.3M across 23 award actions. SCOUT tracks 2 incumbent recompetes ($1.3M) returning to market in the next 24 months.
Which agencies does Nuclear Diagnostic Products of Philadelphia work with?
Nuclear Diagnostic Products of Philadelphia’s firm-wide obligated mix is led by Department of Veterans Affairs (VA) (37%).
What is the UEI for Nuclear Diagnostic Products of Philadelphia?
The Unique Entity ID (UEI) for Nuclear Diagnostic Products of Philadelphia is QJKJD5FKTNP3.
Does Nuclear Diagnostic Products of Philadelphia have contracts coming up for recompete?
Yes — SCOUT tracks 2 incumbent recompetes in the next 24 months (Moderate exposure). Open the recompete section on this page for PIID-level timing.
Seen enough? Run one full capture cycle on Nuclear Diagnostic Products Of Philadelphia, — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.